Avacta Reveals Dual Clinical Advancements In Faridoxorubicin
03 Feb 2026 //
GLOBENEWSWIRE
Avacta Announces Year-End Trading Update
20 Jan 2026 //
GLOBENEWSWIRE
AVA6000 Phase 1b Trial Shows Tumor Shrinkage in Salivary Cancers
17 Dec 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support